Institutional members access full text with Ovid®

Share this article on:

Alemtuzumab induction therapy in HIV-positive renal transplant recipients

Mclean, Florence E.; Gathogo, Esther; Goodall, Dawn; Jones, Rachael; Kinloch, Sabine; Post, Frank A.

doi: 10.1097/QAD.0000000000001413
Correspondence

aDepartment of Renal Medicine, St George's Hospital

bDepartment of Renal Sciences, King's College London

cImperial College Kidney and Transplant Centre, Hammersmith Hospital

dDepartment of HIV Medicine, Chelsea and Westminster Hospital

eDivision of Infection and Immunity, University College London

fDepartment of HIV Research, King's College Hospital NHS Foundation Trust, London, UK.

Correspondence to Florence E. McLean, St George's University Hospitals NHS Foundation Trust, London, SW17 0RE, UK. E-mail: florence.mclean@doctors.org.uk

Received 28 December, 2016

Accepted 12 January, 2017

Copyright © 2017 Wolters Kluwer Health, Inc.